title: [Nephropathy following administration of angiogenesis inhibitors].
authors: A
authors: A
authors: Vello Román
authors: M
authors: M
authors: Samprón Rodríguez
authors: B
authors: B
authors: Pazos Arias
authors: C
authors: C
authors: Romero Reinoso
authors: A
authors: A
authors: Peteiro Cancelo
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D000068258:Bevacizumab; D050476:Bowman Capsule / Q000098:blood supply / Q000502:physiology; D003606:Dacarbazine / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D018450:Disease Progression; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D005354:Fibrosarcoma / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D015432:Glomerulonephritis, Membranoproliferative / Q000139:chemically induced*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D019042:Muscle Neoplasms / Q000188:drug therapy / Q000601:surgery; D050199:Podocytes / Q000502:physiology; D011507:Proteinuria / Q000139:chemically induced; D043823:Taxoids / Q000008:administration & dosage; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000502:physiology; D000093542:Gemcitabine
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D003841:Deoxycytidine; D000077143:Docetaxel; D000068258:Bevacizumab; D003606:Dacarbazine; D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide; D000093542:Gemcitabine